Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The Effect of COVID-19 on Stock Prices of the Biotech Sector in Taiwan ROC


Affiliations
1 Department of Finance, Shih Chien University, Kaohsiung Campus, Taiwan, Province of China
     

   Subscribe/Renew Journal


This study discusses the impact of COVID-19 on the biotech industry vs. TSEC Taiwan 50 Components stocks. We found that the price of stocks in the biotech sector in Taiwan increased due to the COVID-19 pandemic. The financial leverage ratio did not significantly affect the stock price of biotech companies during the COVID-19 pandemic. The number of confirmed diagnosed cases in Taiwan decreases the stock price of biotech companies, for high ROA. In contrast, the number of confirmed diagnosed cases in Taiwan increases the stock price of biotech companies, for high ROE. Investors have more confidence in the biotech firms with shareholder returns during the COVID-19 pandemic.

Keywords

COVID-19, ROA, ROE, Biotech.
Subscription Login to verify subscription
User
Notifications
Font Size



  • The Effect of COVID-19 on Stock Prices of the Biotech Sector in Taiwan ROC

Abstract Views: 308  |  PDF Views: 0

Authors

Yu-Cheng Lai
Department of Finance, Shih Chien University, Kaohsiung Campus, Taiwan, Province of China

Abstract


This study discusses the impact of COVID-19 on the biotech industry vs. TSEC Taiwan 50 Components stocks. We found that the price of stocks in the biotech sector in Taiwan increased due to the COVID-19 pandemic. The financial leverage ratio did not significantly affect the stock price of biotech companies during the COVID-19 pandemic. The number of confirmed diagnosed cases in Taiwan decreases the stock price of biotech companies, for high ROA. In contrast, the number of confirmed diagnosed cases in Taiwan increases the stock price of biotech companies, for high ROE. Investors have more confidence in the biotech firms with shareholder returns during the COVID-19 pandemic.

Keywords


COVID-19, ROA, ROE, Biotech.

References